AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Why the Drop in Aroa Biosurgery Limited's (ASX:ARX) Share Price Shouldn't Surprise Investors
April 08, 2025 10:31 AM AEST| By Team Kalkine MediaHighlights,Aroa Biosurgery (ARX) shares drop 26% in 30 days.,P/S ratio stands at 1.8x, under industry average.,Future growth projections fall below industry trends.,Aroa Biosurgery Limited, trading under the ticker,(,ASX:ARX),, has witnessed a signif...
ASX Healthcare Stock Trading Well Below Pandemic Highs with Consistent Dividends
April 07, 2025 04:35 PM AEST| By Team Kalkine MediaHighlights,Healthcare group Sonic Healthcare has seen a significant decline from its peak during the pandemic,The company operates internationally, offering pathology and diagnostic services,It has delivered consistent dividend growth across many yea...
Mach7 Technologies Faces Market Pressure Amid Sluggish Growth Outlook
April 07, 2025 04:33 PM AEST| By Team Kalkine MediaHighlights,Mach7 Technologies has experienced a notable share price drop in recent weeks,The company’s price-to-sales ratio trails the broader healthcare services sector,Revenue growth expectations remain below industry projections,Mach7 Technologies...
Atomo Diagnostics (ASX:AT1) Broadens Reach with Major Initiatives in Australia and New Zealand
April 07, 2025 01:31 PM AEST| By Team Kalkine MediaHighlights,Expansion in Australia,:,Atomo,Diagnostics rolls out free HIV self-tests across Australia.,Launch in New Zealand,: Introduction of HIV self-test kits through Chemist Warehouse.,Executive Insight,: CEO emphasizes the importance of accessibi...
Exploring Regis Healthcare's (ASX:REG) Revenue Growth and Market Position
April 07, 2025 01:29 PM AEST| By Team Kalkine MediaHighlights,Exceptional Revenue Growth,: Regis Healthcare (REG) has shown impressive revenue growth trends over recent years.,Comparative P/S Ratio,: Its price-to-sales ratio aligns closely with the industry average, despite higher growth forecasts.,h...
Exploring Alcidion Group's Path to Profitability: A Closer Look at Its Strategic Progress
April 07, 2025 11:20 AM AEST| By Team Kalkine MediaHighlights,Alcidion,Group (ALC) nears its breakeven point.,Projected to turn a profit by 2026 based on current growth forecasts.,Unique,position with no debt enhances financial stability.,Alcidion Group (ASX:ALC), a key player in healthcare technolog...
Research reveals that Nyrada's leading medication can avert secondary brain injury.
April 07, 2025 10:30 AM AEST| By Team Kalkine MediaHighlights:,Nyrada Inc has released new findings from a study showing its drug candidate NYR-BI03 demonstrates neuroprotective effects following traumatic brain injury.,The research, conducted with the University of Sydney, Walter Reed Army Institute...
Cochlear Limited's (ASX:COH) Shares May Face Unwelcome Surprises
April 06, 2025 12:31 PM AEST| By Team Kalkine MediaHighlights,Cochlear Limited (ASX:COH) holds a P/E ratio significantly higher than the Australian market average.,The company has demonstrated robust historical earnings growth.,Investors appear optimistic about Cochlear's future, potentially pricing...
Oneview Healthcare (ASX:ONE) Insider Activity Overview
April 06, 2025 12:31 PM AEST| By Team Kalkine MediaHighlights,Insiders purchased more shares than they divested over the past year.,Insider ownership stands at a significant 42% of the company.,Recent insider transaction trends show confidence in future prospects.,Despite the recent 16% dip in share...
Tryptamine Therapeutics: Insider Transactions and Ownership Insights
April 05, 2025 05:31 PM AEDT| By Team Kalkine MediaHighlights,Founder William Garner makes significant stock purchase.,Insider ownership stands at 35% of the company.,Recent purchases suggest perceived long-term value.,In recent developments, William Garner, the Founder and Managing Director of Trypt...
ImExHS Shows Upward Trend in Financial Performance
April 05, 2025 05:30 PM AEDT| By Team Kalkine MediaHighlights,ImExHS (IME) sees revenue growth by 33% in FY 2024.,Net loss narrows by 41% from the previous year.,Radiology segment leads with 68% of total revenue.,ImExHS (ASX:IME) has reported its Full Year 2024 financial results, showcasing a signifi...
Orthocell Limited (ASX:OCC): A Study in Growth and Stability Amid Market Challenges
April 05, 2025 11:32 AM AEDT| By Team Kalkine MediaHighlights,Orthocell Limited (OCC) enjoys a substantial increase in share price.,The company boasts a healthy financial runway of nearly four years.,Revenue growth outstrips the rising costs associated with cash burn.,Over the past year, Orthocell Li...
Doctor Care Anywhere Group Full Year 2024 Earnings Fall Short of Expectations
April 05, 2025 11:31 AM AEDT| By Team Kalkine MediaHighlights,Revenue rises slightly from previous fiscal year.,Net loss narrows significantly.,Forecast shows future revenue growth.,Doctor Care Anywhere Group (ASX:DOC) recently released its full-year financial results for 2024. The company reported a...
Key Factors That Define Strong ASX Stocks
April 04, 2025 06:45 PM AEDT| By Team Kalkine MediaHighlights,Competitive advantages help companies maintain dominance and growth in their industries.,Steady earnings indicate financial strength and operational efficiency.,A solid balance sheet provides flexibility for expansion and resilience.,A com...
Is CSL the Most Defensive Healthcare Stock on the ASX?
April 04, 2025 06:39 PM AEDT| By Team Kalkine MediaHighlights:,CSL operates in the,Healthcare Stocks,sector, producing essential medicines and vaccines.,The company's performance remains stable due to the consistent demand for healthcare services.,Many analysts view CSL as a defensive option within t...
Navigating Trade Tariffs: Impacts Across Key ASX Sectors
April 04, 2025 05:30 PM AEDT| By Team Kalkine MediaHighlights:,Mesoblast (ASX:MSB) maintains tariff exemption amid complex export procedures through Singapore.,Cettire (ASX:CTT) adjusts pricing structures as European luxury imports face new U.S. tariff constraints.,Whitehawk (ASX:WHK) aligns with a U...
Orthocell Secures FDA Clearance for Remplir and Enters US Nerve Repair Market
April 04, 2025 04:39 PM AEDT| By Team Kalkine MediaHighlights:,Orthocell receives FDA approval for Remplir, enabling entry into the US nerve repair market,Remplir will be manufactured in Perth using proprietary technology with no reliance on external royalties,Company prepared for US launch with inve...
Why Is Ansell Limited's Market Standing a Key Focus?
April 04, 2025 01:38 PM AEDT| By Team Kalkine MediaHighlights,Ansell Limited,(ASX:ANN),operates in the protective equipment sector, offering safety solutions across industries.,The company's valuation metrics indicate a divergence from its current trading position.,Various industry and financial fact...
What Does Dimerix Limited’s New Securities Quotation on ASX Mean?
April 04, 2025 01:35 PM AEDT| By Team Kalkine MediaHighlights,Dimerix Limited has issued 5,352 new fully paid ordinary securities on the Australian Securities Exchange (ASX).,The company operates in the biotechnology sector, focusing on therapies for chronic conditions.,This development aligns with i...
Why Is Mesoblast's Market Positioning Drawing Attention?
April 04, 2025 01:31 PM AEDT| By Team Kalkine MediaHighlights,Mesoblast,(ASX:MSB),remains a key entity in stem cell-based therapeutics despite recent stock fluctuations.,The company maintains that its flagship product is not subject to U.S. tariffs due to its manufacturing strategy.,Market sentiment...
Advertise your brand on Kalkine Media